Avance Clinical Appoints Mark Harvill as Chief Executive Officer

“Joining Avance Clinical is a rare opportunity – a chance to lead a purpose-driven organization that’s built on excellence, agility, and care,” said Harvill. “Yvonne has shaped something truly special here. I’m excited to listen, learn, and partner with this exceptional team as we continue delivering on our mission for biotech innovators around the world.”

“It has been a privilege to lead Avance Clinical and work alongside such dedicated and talented individuals,” said Lungershausen. “Mark’s values align deeply with ours, and I have every confidence in his ability to lead with vision and integrity.”

“Mark’s appointment signals the next growth chapter for Avance Clinical,” said Daniel Spasic, Executive Chairman of the Board. “With rising demand for early-stage trials in Australia and the conversion of complex Phase II trials, Mark’s deep sector experience, strategic and  commercial mindset and a proven track record in scaling organizations globally will be key to continued success for our clients, employees, and ultimately the patients we serve. I remain excited to continue the close and productive collaboration with Yvonne that we’ve enjoyed over the years, in her capacity as Co-Founder and Executive Advisor.”

Harvill will divide his time between the company’s headquarters in Adelaide, Australia, and its operations throughout Australia, Korea, Taiwan, India, and the U.S.